drugset / Trial / NCT01005719

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

NCT01005719

Phase 3 Completed 63 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

This study will determine differences between Proton Pump Inhibitors (PPI) formulations relative to their effects on gastric acidity.

Timeline

Start
2009-09
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lansoprazole Other / unclassified 15 mg Oral
Subject Omeprazole Other / unclassified 20 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent 1100 mg Oral

Indications

No indication recorded.